Transgenerational Effects on Disease Susceptibility and Epigenetic Modifications

Molecular and Genetic Medicine

ISSN: 1747-0862

Open Access

Mini Review - (2023) Volume 17, Issue 3

Transgenerational Effects on Disease Susceptibility and Epigenetic Modifications

Richard Brink*
*Correspondence: Richard Brink, Department of Molecular Science, University of Melbourne, Parkville VIC 3010, Australia, Email:
Department of Molecular Science, University of Melbourne, Parkville VIC 3010, Australia

Received: 01-May-2023, Manuscript No. Jmgm-23-102721; Editor assigned: 03-May-2023, Pre QC No. P-102721; Reviewed: 15-May-2023, QC No. Q-102721; Revised: 20-May-2023, Manuscript No. R-102721; Published: 27-May-2023 , DOI: 10.37421/1747-0862.2023.17.605
Citation: Brink, Richard. “Transgenerational Effects on Disease Susceptibility and Epigenetic Modifications.” J Mol Genet Med 17 (2023): 605.
Copyright: © 2023 Brink R. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.


Epigenomics is an emerging field of research that focuses on understanding the complex network of chemical modifications that influence gene expression. It delves into the study of epigenetic mechanisms, which are dynamic and reversible modifications to the DNA and its associated proteins, without altering the underlying genetic code. By exploring epigenetic patterns, researchers can unravel how genes are turned on or off and how they interact with the environment. This article will delve into the fascinating world of epigenomics, its significance in human health and disease, technological advancements and its potential applications. Epigenomics aims to investigate the epigenetic modifications that govern gene expression. It encompasses a broad range of processes, including DNA methylation, histone modifications and chromatin remodelling and non-coding RNA molecules. These mechanisms play crucial roles in development, aging and the response of cells to external stimuli. DNA methylation is a prevalent epigenetic modification, involving the addition of a methyl group to the DNA molecule. Methylation typically occurs at cytosine residues within a CpG dinucleotide context and it often leads to gene silencing. Histone modifications, on the other hand, involve chemical changes to the proteins that support DNA, known as histones. These modifications can either activate or repress gene expression, depending on the specific modification.


Chromatin immunoprecipitation • DNA methylation • Tumor-suppressor genes • Epigenome • Histone


Epigenomic modifications are essential for normal development and cellular differentiation. They are responsible for regulating gene expression patterns, ensuring that cells differentiate into specific cell types with specialized functions. Disruptions in epigenetic processes can lead to a range of diseases, including cancer, neurological disorders and cardiovascular diseases. Cancer epigenetics has been a major focus of epigenomic research. Aberrant DNA methylation patterns and histone modifications are frequently observed in cancer cells, leading to the silencing of tumour-suppressor genes or the activation of oncogenes. By studying these epigenetic alterations, scientists hope to identify biomarkers for early cancer detection and develop targeted therapies.

Literature Review

In recent years, epigenetics has also shed light on the role of epigenetic modifications in neurological disorders such as Alzheimer's disease and schizophrenia. By understanding the underlying epigenetic changes, researchers aim to uncover potential therapeutic targets and develop novel treatment strategies. Technological advancements have been pivotal in driving the field of epigenomics forward. High-throughput sequencing technologies, such as whole-genome bisulphites sequencing and Chromatin Immune Precipitation sequencing (ChIP-seq), enable researchers to map DNA methylation and histone modifications across the entire genome. These techniques provide comprehensive insights into the epigenomic landscape of cells and tissues [1].

Additionally, the development of single-cell epigenomic technologies has revolutionized our understanding of cellular heterogeneity. By analysing individual cells, researchers can uncover epigenetic differences that were previously masked in bulk analyses. This level of resolution has opened new avenues for studying developmental processes, cellular reprogramming and disease progression [2]. Epigenomics holds immense promise for both basic research and clinical applications. The ability to identify and manipulate epigenetic marks has the potential to revolutionize personalized medicine. Epigenetic signatures can serve as diagnostic tools for disease classification, prognosis and prediction of treatment responses. Moreover, epigenetic therapies, such as drugs that target DNA methylation or histone modifications, are currently being developed and tested in clinical trials [3].

Beyond human health, epigenomics can also shed light on the impacts of environmental factors on gene expression. By understanding how epigenetic modifications are influenced by lifestyle, diet and environmental exposures, researchers can develop strategies for disease prevention and intervention. Epigenomic research may provide insights into the effects of stress, pollution and other external factors on gene regulation, offering a deeper understanding of how our environment interacts with our genetics.


Epigenomics has implications in the field of reproductive medicine. It has been shown that certain epigenetic modifications can be inherited across generations, affecting the health and development of offspring. Understanding these trans generational epigenetic effects can help improve assisted reproductive technologies and inform preconception care. Looking ahead, the field of epigenomics is poised for continued growth and innovation. Advances in technology, such as improved sequencing techniques and computational analysis methods, will enable researchers to study epigenetic modifications with greater precision and depth. Integration of epigenomic data with other omics disciplines, such as genomics and transcriptomics, will provide a more comprehensive understanding of gene regulation and its impact on human health [4]. However, challenges remain. Interpreting and understanding the vast amount of epigenomic data generated requires sophisticated bioinformatics tools and computational models. Additionally, ethical considerations surrounding the use of epigenomic information, particularly in areas such as prenatal testing and predictive medicine, need to be carefully addressed [5,6].


Epigenomics offers a powerful approach to unravelling the complex mechanisms of gene regulation. It provides insights into the interplay between genetics and the environment and its potential applications span from disease diagnosis and treatment to personalized medicine and reproductive health. As research progresses and technologies continue to evolve, epigenomics has the potential to revolutionize our understanding of human biology and pave the way for new therapeutic strategies. By deciphering the hidden secrets of gene regulation, we can unlock the mysteries of health and disease, leading to improved outcomes for individuals and populations alike.


We thank the anonymous reviewers for their constructive criticisms of the manuscript. This manuscript was supported by a grant from the Americas Health Foundation (AHF), responsible for the development, organization and implementation of the consensus conference, along with independently selecting the experts to serve on the panel.

Conflict of Interest

The Author declares there is no conflict of interest associated with this manuscript.


  1. Brown, Shelley E., Mario F. Fraga, Ian CG Weaver and Maria Berdasco, et al. "Variations in DNA methylation patterns during the cell cycle of HeLa cells." Epigenetics 2(2007):54-65.
  2. Google Scholar , Crossref, Indexed at

  3. Blackburn, James, Daniel L. Roden, Robert Ng and Jianmin Wu, et al. "Damage‐inducible intragenic demethylation of the human TP53 tumor suppressor gene is associated with transcription from an alternative intronic promoter." Mol Carcinog 55 (2016): 1940-1951.
  4. Google Scholar, Crossref, Indexed at

  5. Serpeloni, Fernanda, Daniel Nätt, Simone Gonçalves de Assis and Elizabeth Wieling, et al. "Experiencing community and domestic violence is associated with epigenetic changes in DNA methylation of BDNF and CLPX in adolescents." Psychophysiol 57 (2020): e13382.
  6. Google Scholar, Crossref, Indexed at

  7. Gjerstad, Julia K., Stafford L. Lightman and Francesca Spiga. "Role of glucocorticoid negative feedback in the regulation of HPA axis pulsatility." Stress 21 (2018): 403-416.
  8. Google Scholar, Crossref, Indexed at

  9. Cavalli, Giacomo and Edith Heard. "Advances in epigenetics link genetics to the environment and disease." Nat 571 (2019): 489-499.
  10. Google Scholar, Crossref, Indexed at

  11. Parade, Stephanie H., Kathryn K. Ridout, Ronald Seifer and David A. Armstrong, et al. "Methylation of the glucocorticoid receptor gene promoter in preschoolers: Links with internalizing behavior problems." Child Dev 87 (2016): 86-97.
  12. Google Scholar, Crossref, Indexed at

Google Scholar citation report
Citations: 3919

Molecular and Genetic Medicine received 3919 citations as per Google Scholar report

Molecular and Genetic Medicine peer review process verified at publons

Indexed In

arrow_upward arrow_upward